Decisions of the Sole Shareholder of UAB EPSO-G

Lithuanian state-owned EPSO-G approved a €3.36 million capital increase in EPSO-G Invest, raising its share capital to €10.77 million. The broader issuance will raise €33.6 million, including €17.14 million from EPSO-G (51%) and €16.46 million from Valstybės investicinis kapitalas (49%), with proceeds supporting additional capital contributions to Rheinmetall Defence Lietuva. The transaction is scheduled to be funded no later than 28 September 2026.

Analysis

The economic signal for RHM is strategic rather than earnings-material: state-backed co-investment lowers execution and political-risk around Baltic production localization, improving the probability that capacity is contracted before construction is fully reflected in backlog. For a defense prime, local sovereign participation can also strengthen its position in follow-on ammunition, maintenance and supply-chain awards across the Baltic/Nordic region, where security-of-supply increasingly outweighs lowest-cost procurement. The near-term P&L contribution is likely immaterial relative to RHM’s existing order base, so this should not justify a standalone earnings upgrade.

Over the next 1-3 months, the relevant catalyst is evidence of binding offtake, permitting milestones, production-start timing, and whether the project secures multi-year framework orders from Lithuania or neighboring NATO members. The 6-18 month upside is multiple support from a higher share of politically protected, geographically diversified capacity; the risk is that European defense budgets remain strong but procurement implementation slips, converting announced industrial policy into delayed revenues. Consensus may overvalue every capacity announcement equally: RHM’s valuation requires delivery against its broader backlog, not incremental announcements. A meaningful thesis break would be a reduction in European ammunition demand forecasts, material project delay, or RHM order-intake/guidance failing to sustain its current capacity-expansion narrative.

Key Decisions for Investors

• Maintain, rather than add aggressively to, a long RHM position on this disclosure alone; treat it as incremental confirmation of Baltic localization. Add only on a 8-12% pullback or after independently verifiable offtake/production milestones, targeting a 6-12 month holding period.
• Use a relative-value expression: long RHM versus short/underweight a broad European industrial proxy such as EXH1 or EU industrial exposure, sized modestly. The thesis is that defense-specific contracted-capacity visibility remains more resilient than cyclical capex if European growth weakens; exit if defense order intake decelerates for two consecutive reporting periods.
• Set an alert for new Lithuanian, Polish, Latvian or Estonian ammunition framework contracts involving RHM. A disclosed multi-year contract with meaningful volume, rather than equity funding alone, would be the catalyst to raise earnings estimates and increase exposure.
• Do not establish a trade in EPSO-G-related entities: the relevant counterparties are not liquid public equities, and the capital commitment is insufficient to infer a tradable change in RHM near-term revenue or margin.